| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/24/2007 | EP1123414B1 Antisense modulation of integrin alpha 4 expression |
| 01/24/2007 | EP1056845B1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 01/24/2007 | EP0973799B1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | EP0951536B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 01/24/2007 | CN1902352A Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 01/24/2007 | CN1902307A Tissue regeneration method |
| 01/24/2007 | CN1902190A 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 01/24/2007 | CN1902189A Plant-origin beta3-adrenoceptor agonist and use of the same |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1902176A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 01/24/2007 | CN1901935A Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
| 01/24/2007 | CN1901927A Alpha-glucosidase activity inhibitor |
| 01/24/2007 | CN1901907A Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 01/24/2007 | CN1900104A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
| 01/24/2007 | CN1900079A New imidazole derivative, method for producing the same and use of the same |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/24/2007 | CN1899615A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899614A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899597A Medicine for treating cold after delivery |
| 01/24/2007 | CN1899584A Huichouning oral administration liquor and its producing method |
| 01/24/2007 | CN1899506A Shenmai oral disintegration tablet and its preparing method |
| 01/24/2007 | CN1899505A Medicine composition for clearing heat and purging-fire |
| 01/24/2007 | CN1899387A Method for preventing and treating child convulsion and its preparing method |
| 01/24/2007 | CN1899374A Miao medicine powder for treating hernia |
| 01/24/2007 | CN1899335A Angong niuhuang soft capsule and its preparing method |
| 01/24/2007 | CN1899318A Composition and its use |
| 01/24/2007 | CN1899272A Stabilized compositions of aqueous reduced coenzyme q solution |
| 01/24/2007 | CN1899250A Application of biological active matteri-abric ketone cellulose and its dervivative |
| 01/24/2007 | CN1899109A Health product for improving quality of produing sperm |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1296381C VEGF peptides and their use for inhibiting angiogenesis |
| 01/24/2007 | CN1296378C CpG-N ODN gene sequence with high immunological activity CpG-S ODN and antagonism CpG-N ODN and use thereof |
| 01/24/2007 | CN1296365C Imidazolinylmethyl aralkylsulfonamides |
| 01/24/2007 | CN1296361C Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296356C CCR-3 receptor antagonists VII |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/24/2007 | CN1296095C Improved mycoplasma hyopneumoniae bacterin vaccine |
| 01/24/2007 | CN1296065C Anti-heat stroke traditional Chinese medicine |
| 01/24/2007 | CN1296053C Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166722 The monohydrochloric acid salt monohydrate, and its preparation by adding hydrochloric acid to a solution of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea in an N,N-dimethylformamide or N,N-dimethylacetamide aprotic solvent, adding ethanol and ethanol and water |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166698 Mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 01/23/2007 | US7166697 V-like domain binding molecules |
| 01/23/2007 | US7166642 Use of cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
| 01/23/2007 | US7166636 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166616 Substituted alkanoic acids |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166607 Substituted indoles |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/23/2007 | US7166579 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 01/23/2007 | US7166576 Methods for preserving organs and tissues |
| 01/23/2007 | US7166450 Hyaluronan synthase gene and uses thereof |
| 01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 01/23/2007 | US7166285 Anti-IL-12 antibodies and compositions |
| 01/23/2007 | US7166283 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 01/23/2007 | CA2348086C Controlled-release pharmaceutical formulations |
| 01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
| 01/23/2007 | CA2329193C Process for synthesizing cox-2 inhibitors |
| 01/23/2007 | CA2288045C A new class of benzoporphyrin derivative photoactive compounds |
| 01/23/2007 | CA2266519C Pyrimidine derivatives and processes for the preparation thereof |
| 01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 01/23/2007 | CA2206754C Benzimidazole derivatives with antihistaminic activity |
| 01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2007007910A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | WO2007007909A1 Combination drug containing diaryl-substituted 5-membered heterocyclic derivative |
| 01/18/2007 | WO2007007890A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 01/18/2007 | WO2007007781A1 Novel use of processed product of blueberry leaf |
| 01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | WO2007007757A1 Pharmaceutical composition containing pparϝ agonist |
| 01/18/2007 | WO2007007737A1 Agent for prevention or treatment of glaucoma |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007625A1 Pharmaceutical for prevention of hypersensitivity |
| 01/18/2007 | WO2007007588A1 Compound having cyclic group with planarity as core |
| 01/18/2007 | WO2007006484A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/18/2007 | WO2006042104A3 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/18/2007 | US20070015830 Use of a retinoid type compound to modulate in vivo the decoupling activity of the protein UCP2 |
| 01/18/2007 | US20070015820 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/18/2007 | US20070015819 Novel compounds |